Market Closed -
Other stock markets
|
Pre-market 07:37:00 | |||
28.66 EUR | +1.70% |
|
28.62 | -0.14% |
05-21 | Scor Unit Updates Senior Bank Loans Flagship Fund | MT |
05-08 | SCOR : Q1 results: Outperformance across the board, top line growth a watchpoint | ![]() |
Summary: Scor SE
- The company presents an interesting fundamental situation from a short-term investment perspective.
Highlights: Scor SE
- The company's profit outlook over the next few years is a strong asset.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.52 for the 2025 fiscal year.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses: Scor SE
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company sustains low margins.
- Revenue estimates are regularly revised downwards for the current and coming years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings Chart: Scor SE
Source: Surperformance
ESG chart: Scor SE
Source: MSCI
Investor (Composite)
Trader (Composite)
ESG MSCI
AA
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
-
Valuation
P/E
EV/Revenue
EV/EBITDA
-
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
ESG
Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SCR Stock
- Ratings Scor SE
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition